Progyny Inc (PGNY)

Gross profit margin

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Gross profit US$ in thousands 253,363 238,799 167,325 112,135 70,059
Revenue US$ in thousands 1,165,810 1,091,910 787,727 501,082 344,979
Gross profit margin 21.73% 21.87% 21.24% 22.38% 20.31%

December 31, 2024 calculation

Gross profit margin = Gross profit ÷ Revenue
= $253,363K ÷ $1,165,810K
= 21.73%

The gross profit margin of Progyny Inc has shown a moderate upward trend over the five-year period from December 31, 2020, to December 31, 2024. Starting at 20.31% in 2020, the gross profit margin increased to 22.38% by the end of 2021. However, there was a slight decline in 2022 to 21.24%, followed by a modest recovery to 21.87% in 2023. In the most recent year, December 31, 2024, the gross profit margin remained relatively stable at 21.73%.

Overall, the trend indicates that Progyny Inc has been able to improve its efficiency in generating profits from its core operations, as reflected in the increasing gross profit margin. However, the fluctuations observed in 2022 and 2023 suggest that the company may have experienced some challenges or changes in its cost structure during those years. The maintenance of a stable gross profit margin in 2024 may indicate efforts to optimize cost management and sustain profitability levels.


Peer comparison

Dec 31, 2024

Company name
Symbol
Gross profit margin
Progyny Inc
PGNY
21.73%
DaVita HealthCare Partners Inc
DVA
82.35%
Sotera Health Co
SHC
55.00%